Financhill
Back

Vanguard S&P Mid-Cap 400 Index Fund ETF Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
60

IVOO
Vanguard S&P Mid-Cap 400 Index Fund ETF

Last Price:
$114.01
Seasonality Move:
6%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
60
Vanguard S&P Mid-Cap 400 Index Fund ETF (IVOO) is a Buy

Is Vanguard S&P Mid-Cap 400 Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard S&P Mid-Cap 400 Index Fund ETF [IVOO] share price is $111.89. The Score for IVOO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • IVOO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

IVOO Stock Price Chart

What is Vanguard S&P Mid-Cap 400 Index Fund ETF's stock price today?

  • The Vanguard S&P Mid-Cap 400 Index Fund ETF share price today is $111.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

IVOO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.73 Buy
Relative Strength Index (14 RSI): 56.9 Buy
Chaikin Money Flow: -35715 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

IVOO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112 Sell
20-day SMA: 110.01 Buy
50-day SMA: 110.08 Buy
200-day SMA: 105.21 Buy
8-day EMA: 111.68 Buy
20-day EMA: 110.74 Buy
50-day EMA: 110.1 Buy
200-day EMA: 107.24 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Vanguard S&P Mid-Cap 400 Index Fund ETF Earnings Growth & IVOO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.35 per share.

Vanguard S&P Mid-Cap 400 Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):